Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Herbert J. Zeh"'
Autor:
Gilbert Z. Murimwa, John D. Karalis, Jennie Meier, Mithin Nehrubabu, Micah Thornton, Matthew Porembka, Sam Wang, Herbert J. Zeh, Adam C. Yopp, Patricio M. Polanco
Publikováno v:
Journal of Surgical Oncology.
Autor:
Brian A. Boone, Kelsey A. Musgrove, Carl Schmidt, Alan A Thomay, Pavan Rao, Britney R. Harris, Melissa E. Hogg, Herbert J. Zeh, Amer H. Zureikat, J. Wallis Marsh
Publikováno v:
J Surg Oncol
Introduction The learning curve associated with robotic pancreatoduodenectomy (RPD) is a hurdle for new programs to achieve optimal results. Since early analysis, robotic training has recently expanded, and the RPD approach has been refined. The purp
Autor:
Jennifer Steve, Heather L. Jones, Mazen S. Zenati, Samantha Perkins, James F. Pingpank, Melissa E. Hogg, Haroon A. Choudry, Herbert J. Zeh, David L. Bartlett, Mashaal Dhir, Amber K. Clifford, Matthew P. Holtzman, Amer H. Zureikat, James C. Padussis
Publikováno v:
Journal of Surgical Oncology. 114:342-347
Background Hepatic artery infusion (HAI) chemotherapy can be combined with systemic chemotherapy for the treatment of isolated unresectable colorectal liver metastases (IU-CRLM) and intrahepatic cholangiocarcinoma (U-ICC). However, HAI pump placement
Autor:
Aatur D. Singhi, Mazen S. Zenati, Shirin Sabbaghian, Alyssa M. Krasinskas, J. Wallis Marsh, Herbert J. Zeh, A. James Moser, Amer H. Zureikat, Brian A. Boone
Publikováno v:
Journal of Surgical Oncology. 110:171-175
Background and Objectives Venous resection of locally advanced pancreatic cancer is associated with increased morbidity and mortality; therefore identification of patients most likely to benefit from this aggressive surgical approach is an important
Autor:
Barry C. Lembersky, Jennifer Steve, Ronald G. Stoller, Nathan Bahary, Brian A. Boone, Alyssa M. Krasinskas, Michael K. Gibson, Amer H. Zureikat, Herbert J. Zeh
Publikováno v:
Journal of Surgical Oncology. 108:236-241
Background Trials examining FOLFIRINOX in metastatic pancreatic cancer demonstrate higher response rates compared to gemcitabine-based regimens. There is currently limited experience with neoadjuvant FOLFIRINOX in pancreatic cancer.
Autor:
Joel M. Baumgartner, Herbert J. Zeh, Amer H. Zureikat, Matthew P. Holtzman, Heather L. Jones, Lekshmi Ramalingam, Steven A. Ahrendt, James F. Pingpank, Haroon A. Choudry, David L. Bartlett
Publikováno v:
Journal of Surgical Oncology. 107:329-334
Background: and Objectives Peritoneal sarcomatosis responds poorly to systemic chemotherapy and demonstrates high rates of recurrence after resection. We sought to determine perioperative and oncologic outcomes after cytoreductive surgery (CRS) and h
Autor:
Mashaal, Dhir, Mazen S, Zenati, James C, Padussis, Heather L, Jones, Samantha, Perkins, Amber K, Clifford, Jennifer, Steve, Melissa E, Hogg, Haroon A, Choudry, Matthew P, Holtzman, Herbert J, Zeh, James F, Pingpank, David L, Bartlett, Amer H, Zureikat
Publikováno v:
Journal of surgical oncology. 114(3)
Hepatic artery infusion (HAI) chemotherapy can be combined with systemic chemotherapy for the treatment of isolated unresectable colorectal liver metastases (IU-CRLM) and intrahepatic cholangiocarcinoma (U-ICC). However, HAI pump placement requires a
Publikováno v:
Journal of Surgical Oncology. 106:911-917
Pseudomyxoma peritonei (PMP) is characterized by intraperitoneal dissemination of mucinous ascites. This malignancy frequently recurs despite aggressive locoregional therapies, demonstrates chemo-insensitivity and lacks targeted therapies. This revie
Autor:
Brian A, Boone, Shirin, Sabbaghian, Mazen, Zenati, J Wallis, Marsh, A James, Moser, Amer H, Zureikat, Aatur D, Singhi, Herbert J, Zeh, Alyssa M, Krasinskas
Publikováno v:
Journal of surgical oncology. 110(2)
Venous resection of locally advanced pancreatic cancer is associated with increased morbidity and mortality; therefore identification of patients most likely to benefit from this aggressive surgical approach is an important goal. Loss of SMAD4 staini
Autor:
Joel M, Baumgartner, Steven A, Ahrendt, James F, Pingpank, Matthew P, Holtzman, Lekshmi, Ramalingam, Heather L, Jones, Amer H, Zureikat, Herbert J, Zeh, David L, Bartlett, Haroon A, Choudry
Publikováno v:
Journal of surgical oncology. 107(4)
Peritoneal sarcomatosis responds poorly to systemic chemotherapy and demonstrates high rates of recurrence after resection. We sought to determine perioperative and oncologic outcomes after cytoreductive surgery (CRS) and hyperthermic intraperitoneal